Correlation Between Galera Therapeutics and AC Immune
Can any of the company-specific risk be diversified away by investing in both Galera Therapeutics and AC Immune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Galera Therapeutics and AC Immune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Galera Therapeutics and AC Immune, you can compare the effects of market volatilities on Galera Therapeutics and AC Immune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Galera Therapeutics with a short position of AC Immune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Galera Therapeutics and AC Immune.
Diversification Opportunities for Galera Therapeutics and AC Immune
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Galera and ACIU is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Galera Therapeutics and AC Immune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AC Immune and Galera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Galera Therapeutics are associated (or correlated) with AC Immune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AC Immune has no effect on the direction of Galera Therapeutics i.e., Galera Therapeutics and AC Immune go up and down completely randomly.
Pair Corralation between Galera Therapeutics and AC Immune
If you would invest 258.00 in Galera Therapeutics on September 30, 2024 and sell it today you would earn a total of 0.00 from holding Galera Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 1.56% |
Values | Daily Returns |
Galera Therapeutics vs. AC Immune
Performance |
Timeline |
Galera Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
AC Immune |
Galera Therapeutics and AC Immune Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Galera Therapeutics and AC Immune
The main advantage of trading using opposite Galera Therapeutics and AC Immune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Galera Therapeutics position performs unexpectedly, AC Immune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AC Immune will offset losses from the drop in AC Immune's long position.Galera Therapeutics vs. Mereo BioPharma Group | Galera Therapeutics vs. Terns Pharmaceuticals | Galera Therapeutics vs. PDS Biotechnology Corp | Galera Therapeutics vs. Inozyme Pharma |
AC Immune vs. Pmv Pharmaceuticals | AC Immune vs. MediciNova | AC Immune vs. Pharvaris BV | AC Immune vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |